The seed technology developer went public after raising more than $100m in funding from investors including BASF.
Arcadia Biosciences, a US-based agricultural biotechnology developer backed by chemical producer BASF, will float on Nasdaq today in a $65.6m initial public offering issuing 8.2 million shares priced at $8 each.
Founded in 2002, Arcadia’s biotechnology enables crops to be grown more efficiently and in a more environmentally friendly way, while reducing production costs at the same time.
Arcadia raised approximately $101m in funding prior to the IPO. BASF Venture Capital, the corporate venturing arm of BASF, participated in a…
